This statistic presents the top ten FDA-approved multiple sclerosis drugs based on global revenue in 2013. That year, Tecfidera, created by Biogen Idec, generated revenue of more than *** million U.S. dollars.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Genetic Engineering & Biotechnology News. (February 18, 2014). Ranking of the top ten multiple sclerosis drugs worldwide in 2013, by revenue (in millions of U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 02, 2026, from /statistics/1630221/the-main-medications-for-multiple-sclerosis-in-the-united-states-by-revenue/
Genetic Engineering & Biotechnology News. "Ranking of the top ten multiple sclerosis drugs worldwide in 2013, by revenue (in millions of U.S. dollars)." Chart. February 18, 2014. ÌÇÐÄÆƽâ°æ. Accessed August 02, 2026. /statistics/1630221/the-main-medications-for-multiple-sclerosis-in-the-united-states-by-revenue/
Genetic Engineering & Biotechnology News. (2014). Ranking of the top ten multiple sclerosis drugs worldwide in 2013, by revenue (in millions of U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 02, 2026. /statistics/1630221/the-main-medications-for-multiple-sclerosis-in-the-united-states-by-revenue/
Genetic Engineering & Biotechnology News. "Ranking of The Top Ten Multiple Sclerosis Drugs Worldwide in 2013, by Revenue (in Millions of U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 18 Feb 2014, /statistics/1630221/the-main-medications-for-multiple-sclerosis-in-the-united-states-by-revenue/
Genetic Engineering & Biotechnology News, Ranking of the top ten multiple sclerosis drugs worldwide in 2013, by revenue (in millions of U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1630221/the-main-medications-for-multiple-sclerosis-in-the-united-states-by-revenue/ (last visited August 02, 2026)
Ranking of the top ten multiple sclerosis drugs worldwide in 2013, by revenue (in millions of U.S. dollars) [Graph], Genetic Engineering & Biotechnology News, February 18, 2014. [Online]. Available: /statistics/1630221/the-main-medications-for-multiple-sclerosis-in-the-united-states-by-revenue/
